Quick Answer
Sabra Health Care REIT, Inc. reported Cash and Equivalents of $71.54 million for fiscal year 2025.
Sabra Health Care REIT, Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $71.54M | +18.3% |
| 2024 | $60.47M | +46.5% |
| 2023 | $41.28M | -16.3% |
| 2022 | $49.31M | -56.0% |
| 2021 | $112.00M | +89.6% |
| 2020 | $59.08M | +51.1% |
| 2019 | $39.10M | -22.2% |
| 2018 | $50.23M | -90.3% |
| 2017 | $518.63M | +1920.9% |
| 2016 | $25.66M | +245.2% |
| 2015 | $7.43M | -88.0% |
| 2014 | $61.79M | +1334.4% |
| 2013 | $4.31M | -74.8% |
| 2012 | $17.10M | -59.5% |
| 2011 | $42.25M | +0.0% |
| 2010 | $42.25M | -37.1% |
| 2010 | $67.13M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $200.60M | +218.4% | +110.8% |
| June 30, 2025 | $95.17M | +161.5% | +320.1% |
| March 31, 2025 | $22.65M | -62.2% | -62.5% |
| December 31, 2024 | $60.47M | +46.5% | -4.0% |
| September 30, 2024 | $63.00M | +89.5% | +73.1% |
| June 30, 2024 | $36.40M | +33.6% | -39.3% |
| March 31, 2024 | $59.93M | +78.7% | +45.2% |
| December 31, 2023 | $41.28M | -16.3% | +24.1% |
- Sabra Health Care REIT, Inc. showed an increase of +18.3% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2010–2025 period, Sabra Health Care REIT, Inc.’s cash and equivalents has grown by 6.6% (from $67.13 million to $71.54 million).
- The most recent figure is from Sabra Health Care REIT, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: